A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer
Clinical trial NCT05016973 · UNKNOWN
Trial details
- NCT number
- NCT05016973
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.